HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
L He Selected Research
L He Research Topics
Disease
41
Neoplasms (Cancer)
11/2020 - 03/2000
23
Schizophrenia (Dementia Praecox)
11/2017 - 07/2003
17
Hypoxia (Hypoxemia)
08/2021 - 01/2000
15
Infections
09/2021 - 04/2001
9
Hemorrhage
02/2022 - 11/2001
8
Type 2 Diabetes Mellitus (MODY)
07/2022 - 07/2009
8
Necrosis
01/2020 - 03/2001
6
Periodontitis
07/2022 - 11/2001
6
Atrial Fibrillation
03/2022 - 06/2017
6
Neoplasm Metastasis (Metastasis)
01/2017 - 03/2013
5
Chronic Periodontitis
07/2022 - 01/2000
5
Obesity
01/2022 - 01/2001
5
Pain (Aches)
01/2020 - 07/2006
5
Carcinogenesis
02/2018 - 01/2015
5
Body Weight (Weight, Body)
01/2017 - 08/2001
5
Lung Injury
03/2008 - 12/2000
5
Alzheimer Disease (Alzheimer's Disease)
07/2004 - 12/2000
4
Hypertension (High Blood Pressure)
01/2022 - 06/2016
4
Breast Neoplasms (Breast Cancer)
01/2021 - 04/2007
4
Stomach Neoplasms (Stomach Cancer)
02/2018 - 01/2008
4
Pneumonia (Pneumonitis)
05/2017 - 11/2000
4
Hypersensitivity (Allergy)
04/2012 - 02/2009
3
Osteoporosis
05/2022 - 09/2015
3
Ischemic Stroke
01/2022 - 04/2014
3
Hyperglycemia
06/2021 - 02/2007
3
Inflammation (Inflammations)
03/2021 - 07/2006
3
Wounds and Injuries (Trauma)
03/2021 - 07/2000
3
Hepatocellular Carcinoma (Hepatoma)
12/2016 - 04/2003
3
Ovarian Neoplasms (Ovarian Cancer)
01/2015 - 01/2007
3
Experimental Melanoma
12/2001 - 10/2000
3
Leukemia
08/2001 - 03/2000
3
Shock
04/2001 - 02/2000
2
Thromboembolism
03/2022 - 01/2022
2
Diabetes Mellitus
02/2022 - 04/2020
2
Transient Ischemic Attack
01/2022 - 06/2017
2
Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2022 - 09/2020
2
Insulin Resistance
01/2022 - 06/2018
2
Heart Failure
09/2021 - 04/2020
2
Coronary Artery Disease (Coronary Atherosclerosis)
09/2021 - 01/2010
2
Vomiting
08/2021 - 04/2007
2
Trigeminal Neuralgia (Tic Douloureux)
01/2020 - 07/2006
2
Hyperalgesia
01/2020 - 12/2011
2
Bronchitis
01/2020 - 07/2018
Drug/Important Bio-Agent (IBA)
20
Proteins (Proteins, Gene)
FDA Link
02/2021 - 01/2000
12
Vaccines
IBA
08/2005 - 03/2000
11
DNA (Deoxyribonucleic Acid)
IBA
01/2019 - 05/2001
11
Cytokines
IBA
01/2015 - 10/2000
10
Messenger RNA (mRNA)
IBA
03/2017 - 02/2000
9
Pharmaceutical Preparations
IBA
01/2022 - 10/2001
9
Biological Products
IBA
02/2021 - 07/2004
9
Antigens
IBA
11/2020 - 03/2001
8
Glucose (Dextrose)
FDA Link
Generic
06/2022 - 07/2000
7
Biomarkers (Surrogate Marker)
IBA
01/2022 - 12/2000
6
Peptides (Polypeptides)
IBA
01/2022 - 03/2001
6
DNA Vaccines
IBA
02/2006 - 05/2001
5
Lipids
IBA
07/2022 - 04/2001
5
Blood Glucose (Blood Sugar)
IBA
07/2022 - 06/2016
5
Enzymes
IBA
11/2020 - 06/2000
5
Neurotransmitter Agents (Neurotransmitter)
IBA
01/2020 - 01/2000
5
MicroRNAs (MicroRNA)
IBA
07/2015 - 03/2013
5
Apolipoproteins
IBA
10/2003 - 07/2000
5
Interleukin-18 (Interleukin 18)
IBA
12/2001 - 10/2000
4
Paclitaxel (Taxol)
FDA Link
Generic
12/2010 - 04/2000
4
Calreticulin
IBA
02/2006 - 03/2000
4
A-Form DNA (A-DNA)
IBA
08/2005 - 05/2001
3
Tablets
IBA
05/2022 - 09/2015
3
Hemoglobins (Hemoglobin)
IBA
02/2022 - 06/2015
3
Oxygen (Dioxygen)
IBA
08/2021 - 02/2005
3
Small Interfering RNA (siRNA)
IBA
06/2021 - 01/2008
3
Adenosine Triphosphate (ATP)
IBA
12/2019 - 09/2003
3
Risperidone (Risperdal Consta)
FDA Link
Generic
11/2017 - 11/2008
3
Nicotine
FDA Link
01/2017 - 01/2000
3
Fatty Acids (Saturated Fatty Acids)
IBA
01/2017 - 10/2001
3
Doxorubicin (Adriamycin)
FDA Link
Generic
08/2013 - 08/2008
3
NADPH Oxidases (NAD(P)H oxidase)
IBA
05/2010 - 12/2005
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
02/2009 - 02/2000
3
Lipopolysaccharides
IBA
03/2008 - 12/2003
3
RNA (Ribonucleic Acid)
IBA
11/2006 - 02/2001
3
Apolipoproteins E (ApoE)
IBA
10/2003 - 12/2000
2
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
01/2022 - 04/2020
2
Anticoagulants
IBA
01/2022 - 04/2021
2
Angiotensin Receptor Antagonists
IBA
01/2022 - 04/2020
2
Apelin
IBA
01/2022 - 01/2022
2
Insulin (Novolin)
FDA Link
01/2022 - 03/2013
2
Carbapenems (Carbapenem Antibiotics)
IBA
09/2021 - 09/2018
2
Tensins
IBA
02/2021 - 10/2017
2
Cadherins (E-Cadherin)
IBA
02/2021 - 12/2014
2
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
02/2021 - 10/2017
2
Estrogen Receptors
IBA
01/2021 - 01/2017
2
human ERBB2 protein
IBA
01/2021 - 02/2018
2
Cholesterol
IBA
11/2020 - 06/2012
2
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
04/2020 - 02/2007
2
Oxidoreductases (Dehydrogenase)
IBA
12/2019 - 12/2005
Therapy/Procedure
27
Therapeutics
07/2022 - 01/2000
10
Immunotherapy
01/2010 - 02/2001
4
Drug Therapy (Chemotherapy)
06/2015 - 09/2001
3
Glycemic Control
07/2022 - 02/2022
3
Intraperitoneal Injections
12/2016 - 07/2006
2
Punctures
05/2021 - 06/2017
2
Length of Stay
07/2020 - 03/2016